Latest News

07/06/2024

British Society for Heart Failure Manifesto

In the light of the snap General Election scheduled for 4th July 2024, we are pleased to share with you the British Society for Heart Failure Manifesto which focuses on the 25in25 initiative and which has been shared with policymakers across the health landscape. We hope that the Manifesto will go some way to support our shared ambitions.

In brief, we ask for consideration of the following:

The British Society for Heart Failure (BSH) is calling on all political parties to:

  • Adopt, UK-wide, the 25in25 initiative[i], supported by 60+ healthcare organisations, which aims to reduce deaths due to heart failure by 25% in the first year of diagnosis within the next 25 years, saving 10,000 lives every year

  • Prioritise patient care by supporting clinicians across specialities and healthcare systems to work together to prevent avoidable heart failure deaths, making every contact count

  • Fund recruitment and retention of more heart failure specialist clinicians

  • Prioritise the heart failure training, education and upskilling of clinicians delivering HF care across specialities and healthcare landscapes, supported by the British Society for Heart Failure, to expedite diagnosis through better symptom recognition, earlier testing and collaboration

  • Direct funding into systematic case-finding of undetected heart failure through the 25in25 implementation programme which will lead to optimisation and equality of care for all those in communities who need it. #FindMe

 

Happy to provide further information and context, as necessary. Please do like and share our social media posts:

FaceBook: https://www.facebook.com/share/p/FyqjgA8TteZ7ZZ56/


Download HERE

[i] British Society for Heart Failure 25in25 initiative: https://www.bsh.org.uk/25in25 Accessed 5Jun24

06/06/2024

BSH ANNUAL MEETING TICKET SALES - NOW OPEN!

We are excited to announce that registrations for the BSH 27th Annual Meeting are now open!

Date: 21-22 November 2024

Venue: QEII Conference Centre, London

Members will be able to purchase discounted EARLY BIRD tickets until 30 September 2024.

For more information on the meeting  and to register, please head over to the event website -

 BSH Annual Meeting

You can download the programme here - BSH AM Programme 2024 (1).pdf

For any questions, please see the FAQs on the website or contact events@bsh.org.uk

We look forward to seeing you at the meeting in November!

12/04/2024

BSH Releases Advice on NT-proBNP cut-offs for Acute Heart Failure in the Emergency Department

The British Society for Heart Failure endorses the European Society for Cardiology Heart Failure Association clinical consensus statement recommending NT-proBNP age-related cut-offs for identification of acute heart failure.

Heart Health Survey

Edinburgh Napier University and Robert Gordon University are working with the James Lind Alliance to conduct a survey. The survey is looking into the most popular questions that patients, carers and clinical professionals have about digital technology and how it is used in heart disease and heart condition management and prevention. Those who need the research most should have a say in what is researched, this is your chance to have yours.

If you are a patient with a heart condition or heart disease, you care for someone who has a heart condition or heart disease, or you are a clinical professional whose work involves those with heart conditions or heart disease, then we ask you to please take a moment to complete this survey.

You can find our survey at Survey 1 - Digital Heart PSP (napier.ac.uk). Please take some time to fill it out and share it with those who may be interested. If you would like a paper copy, please contact the team at DigitalHeart@napier.ac.uk

Semaglutide improves symptoms of heart failure

In recent clinical trials, the weight-loss drug semaglutide showed promising development in improving the symptoms of heart failure. The trial was conducted over 2years with 529 patients from 13 countries in Europe, North America, South America and Asia. The announcement was made on the first day of the European Society of Cardiology conference this weekend. Our Chair of the BSH Patient Advisory Panel was interviewed by Sky News for his reaction:

NICE Final Draft Guidance

NICE has released final draft guidance for Paxlovid today and we are pleased to report that Heart Failure is in the patient inclusion list.  

This decision marks a potentially positive step forward in enhancing treatment options for individuals suffering from Heart Failure

Access the full guidance
here